BRPI0417762A8 - Organismo vivo, um plasmodium, método para inocular um hospedeiro vertebrado contra malária, composição de vacina, uso de um organismo vivo, um plasmodium, e, método de produção de uma composição de vacina - Google Patents

Organismo vivo, um plasmodium, método para inocular um hospedeiro vertebrado contra malária, composição de vacina, uso de um organismo vivo, um plasmodium, e, método de produção de uma composição de vacina

Info

Publication number
BRPI0417762A8
BRPI0417762A8 BRPI0417762A BRPI0417762A BRPI0417762A8 BR PI0417762 A8 BRPI0417762 A8 BR PI0417762A8 BR PI0417762 A BRPI0417762 A BR PI0417762A BR PI0417762 A BRPI0417762 A BR PI0417762A BR PI0417762 A8 BRPI0417762 A8 BR PI0417762A8
Authority
BR
Brazil
Prior art keywords
plasmodium
vaccine composition
live
inocculating
production
Prior art date
Application number
BRPI0417762A
Other languages
English (en)
Inventor
H I Kappe Stefan
C Matuschewski Kai-Uwe
Mueller Ann-Kristin
Original Assignee
Seattle Biomedical Res Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seattle Biomedical Res Institute filed Critical Seattle Biomedical Res Institute
Publication of BRPI0417762A publication Critical patent/BRPI0417762A/pt
Publication of BRPI0417762A8 publication Critical patent/BRPI0417762A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

ORGANISMO VIVO, UM PLASMODIUM, MÉTODO PARA INOCULAR UM HOSPEDEIRO VERTEBRADO CONTRA MALÁRIA, COMPOSIÇÃO DE VACINA, USO DE UM ORGANISMO VIVO, UM PLASMODIUM, E, MÉTODO DE PRODUÇÃO DE UMA COMPOSIÇÃO DE VACINA. Método para inocular um hospedeiro vertebrado contra malária, por administração, ao hospedeiro, de um organismo vivo, um Plasmodium, que é geneticamente engenheirado para interromper uma função do gene específico do fígado.
BRPI0417762A 2003-12-19 2004-12-20 Organismo vivo, um plasmodium, método para inocular um hospedeiro vertebrado contra malária, composição de vacina, uso de um organismo vivo, um plasmodium, e, método de produção de uma composição de vacina BRPI0417762A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53147903P 2003-12-19 2003-12-19
US63122804P 2004-11-26 2004-11-26
PCT/US2004/043023 WO2005063991A2 (en) 2003-12-19 2004-12-20 Live genetically attenuated malaria vaccine

Publications (2)

Publication Number Publication Date
BRPI0417762A BRPI0417762A (pt) 2007-04-17
BRPI0417762A8 true BRPI0417762A8 (pt) 2015-12-22

Family

ID=34742995

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417762A BRPI0417762A8 (pt) 2003-12-19 2004-12-20 Organismo vivo, um plasmodium, método para inocular um hospedeiro vertebrado contra malária, composição de vacina, uso de um organismo vivo, um plasmodium, e, método de produção de uma composição de vacina

Country Status (10)

Country Link
US (3) US7718165B2 (pt)
EP (1) EP1706418B1 (pt)
JP (1) JP2007515170A (pt)
KR (1) KR20060123346A (pt)
AU (1) AU2004309380B2 (pt)
BR (1) BRPI0417762A8 (pt)
CA (1) CA2551193C (pt)
OA (1) OA13341A (pt)
SG (1) SG149058A1 (pt)
WO (1) WO2005063991A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070087021A1 (en) * 1997-08-20 2007-04-19 Eng-Hong Lee Method of protecting against chronic infections
US8802919B2 (en) * 2002-04-05 2014-08-12 Sanaria Inc. Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production
US8168166B2 (en) * 2003-12-19 2012-05-01 Seattle Biomedical Research Institute Live genetically attenuated malaria vaccine
BRPI0417762A8 (pt) * 2003-12-19 2015-12-22 Seattle Biomedical Res Institute Organismo vivo, um plasmodium, método para inocular um hospedeiro vertebrado contra malária, composição de vacina, uso de um organismo vivo, um plasmodium, e, método de produção de uma composição de vacina
US20050206225A1 (en) * 2004-03-18 2005-09-22 Ford Global Technologies, Llc Method and apparatus for predicting the position of a trailer relative to a vehicle
AP2008004448A0 (en) 2005-09-30 2008-04-30 Seattle Biomedical Res Inst Plasmodium liver stage antigens
US8128921B2 (en) * 2006-07-11 2012-03-06 University Of Connecticut Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination
US8153116B2 (en) 2006-07-11 2012-04-10 University Of Connecticut Use of conditional plasmodium strains lacking an essential gene in malaria vaccination
AU2008202114B2 (en) * 2008-05-13 2011-08-25 Ruprecht-Karls-Universitat Heidelberg Live genetically attenuated malaria vaccine
EP2163627A1 (en) 2008-09-12 2010-03-17 Bernhard-Nocht-Institut für Tropenmedizin Attenuated liver-stage Plasmodium and vaccin containing the same
SG172856A1 (en) 2009-01-16 2011-08-29 Sanaria Inc Purified plasmodium and vaccine compositions
US20110010782A1 (en) * 2009-07-09 2011-01-13 Microsoft Corporation Adapting parasites to combat disease
US20120288525A1 (en) 2011-05-11 2012-11-15 Chakravarty Sumana Pharmaceutical compositions comprising attenuated plasmodium sporozoites and glycolipid adjuvants
IN2014MN02275A (pt) * 2012-04-17 2015-08-07 Inst De Medicina Molecular
EP2956166B1 (en) 2013-01-25 2019-01-16 Sanaria Inc. Genetic attenuation of plasmodium by b9 gene disruption
WO2015132338A1 (en) * 2014-03-06 2015-09-11 Stichting Katholieke Universiteit A genetically attenuated, live organism of the plasmodium genus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681762A (en) * 1979-05-23 1987-07-21 Research Corporation Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype
EP0730466A4 (en) * 1993-09-10 1999-04-14 Univ New York COMPOSITIONS AND METHOD FOR INHIBITING THE INVASION OF HEPATOCYTES BY MALARIASPOROZOITES
PT841392E (pt) * 1996-11-12 2004-11-30 Univ Auburn Vacina viva atenuada de neospora
EP1100925B1 (en) 1998-07-31 2006-01-18 Akzo Nobel N.V. Attenuated equine herpesvirus
CN100393866C (zh) 2002-09-20 2008-06-11 英特威国际有限公司 减毒活寄生虫疫苗
OA13012A (en) 2002-11-20 2006-11-10 Sanaria Inc Method for the prevention of malaria.
BRPI0417762A8 (pt) * 2003-12-19 2015-12-22 Seattle Biomedical Res Institute Organismo vivo, um plasmodium, método para inocular um hospedeiro vertebrado contra malária, composição de vacina, uso de um organismo vivo, um plasmodium, e, método de produção de uma composição de vacina

Also Published As

Publication number Publication date
BRPI0417762A (pt) 2007-04-17
US7718165B2 (en) 2010-05-18
JP2007515170A (ja) 2007-06-14
AU2004309380B2 (en) 2010-04-29
US7261884B2 (en) 2007-08-28
WO2005063991A3 (en) 2005-09-09
SG149058A1 (en) 2009-01-29
AU2004309380A1 (en) 2005-07-14
CA2551193A1 (en) 2005-07-14
US20080032388A1 (en) 2008-02-07
US20070009556A1 (en) 2007-01-11
OA13341A (en) 2007-04-13
EP1706418B1 (en) 2018-08-22
CA2551193C (en) 2011-02-01
WO2005063991A2 (en) 2005-07-14
US7122179B2 (en) 2006-10-17
US20050226896A1 (en) 2005-10-13
KR20060123346A (ko) 2006-12-01
EP1706418A2 (en) 2006-10-04

Similar Documents

Publication Publication Date Title
BRPI0417762A (pt) organismo vivo, um plasmodium, método para inocular um hospedeiro vertebrado contra malária, composição de vacina, uso de um organismo vivo, um plasmodium, e, método de produção de uma composição de vacina
WO2023283642A3 (en) Pan-human coronavirus concatemeric vaccines
CR20110206A (es) Método de uso de una sepa de bacillus subtilis para mejorar la salud de animales
EP2349279A4 (en) MODIFIERS OF ALDEHYDE DEHYDROGENASE AND METHODS OF USE THEREOF
WO2007136936A3 (en) Dermis-derived cells for tissue engineering applications
WO2012084699A3 (en) Cosmetic composition comprising a cucurbic acid compound and an acrylic copolymer
ATE525984T1 (de) Belüftetes prothesensystem
CY1112853T1 (el) Ενδιαμεση ενωση 4-(ακετυλαμινο)-3-[(4-χλωροφαινυλ)θειο]-2-μεθυλ-1η-ινδολη-1-οξικο οξυ αιθυλεστερα
CR10263A (es) Induccion y estabilizacion de actividad enzimatica en microorganismos
CO6640205A2 (es) Microorganismos y metodos para la biosintesis de p-toluato y tereftalato
BR112013025120A2 (pt) composição e processo de tratamento cosmético não-terapêutico
BR112013009802A8 (pt) Fotoiniciadores polimerizáveis para composições curáveis por leds
CY1115690T1 (el) Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων
UY28253A1 (es) Nueva difenilazetidinona con propiedades fisiologicas mejoradas, procedimiento para su preparación, medicamentos que comprenden este compuesto y su uso.
DE60330708D1 (de) Impfstoff gegen das west-nile-virus
DK1753440T3 (da) Oral administrationsform indeholdende probiotiske bakterier
RU2008111877A (ru) Способ приготовления стабилизатора, ускорителя вулканизации или модифицированного посредством микроорганизма природного каучука
CL2008003262A1 (es) Vacuna que comprende lactococcus garviae, pasteurella piscicida, vibrio anguillarum y nocardia seriolae; y uso de dichas bacterias para combatir infecciones de nocardia en peces.
ECSP055869A (es) Vacuna hpv-16 y -18 l1 vlp
NO20065535L (no) Behandling av respiratorisk sykdom
SE0300795D0 (sv) Composition comprising iscom particles and live micro-organisms
ATE467420T1 (de) Verfahren zur verwendung von guava-extrakt und zusammensetzung mit guava-extrakt
JP2007515170A5 (pt)
BRPI0514422A (pt) biotransformação enantioseletiva para o preparo de intermediários do inibidor de proteìna tirosina quinase
DE602006004186D1 (de) VERFAHREN ZUR HERSTELLUNG EINER NICHTAROMATISCHEN L-AMINOSÄURE UNTER VERWENDUNG EINES BAKTERIUMS DERRESSION DES csrA-GENS

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: C12N 15/30

Ipc: C12N 15/30 (2006.01), A61K 39/015 (2006.01), A61P

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements